New study explores Over-the-Counter glucose monitor for postpartum health

NCT ID NCT07356986

First seen Jan 22, 2026 · Last updated Apr 28, 2026 · Updated 12 times

Summary

This study will test the Dexcom Stelo, an over-the-counter continuous glucose monitor, in 50 women who had gestational diabetes in their most recent pregnancy. The goal is to see how well the device works after childbirth and to gather information on blood sugar patterns. Participants will use the monitor for up to 6 weeks postpartum and provide blood samples for comparison.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for POSTPARTUM are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Oregon Health & Science University

    Portland, Oregon, 97239, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

  • Sansum Diabetes Research Institute

    Santa Barbara, California, 93105, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • University of Pennsylvania

    Philadelphia, Pennsylvania, 19104, United States

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.